Foronda, 38, was arrested on Friday, March 28, for allegedly illegally performing plastic surgery procedures that left one ...
Many people are under the impression they have a natural bond with their dogs, and can read all their body language signals ...
Because chemogenetic control relies on DREADD expression levels, understanding and quantifying the temporal dynamics of their expression is crucial for planning long-term experiments in monkeys. In ...
A precision medicine workflow integrating proteomics and personalized xenograft models was developed and applied to an ...
The FDA has approved guselkumab (Tremfya) as the first IL-23 inhibitor offering both subcutaneous and intravenous induction ...
The revelation that Penn Medicine is working to help save the troubled health system came during an emergency court hearing. Efforts to sell Crozer Health have taken several twists in the past 24 ...
News of a fresh investigational program was putting some zip into the shares of gene-editing company Prime Medicine (NASDAQ ... were propelling the company's stock over 12% higher week to date ...
Scotiabank increased their target price on Disc Medicine from $73.00 to $75.00 and gave the stock a “sector outperform” rating in a report on Monday, March 3rd. HC Wainwright reissued a “buy ...
With the exception of "Editorial use only" photos (which can only be used in editorial projects and can't be modified), the possibilities are limitless. Learn more about royalty-free video footage or ...
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Prime Medicine wasn’t one of them. The 10 stocks that made the ...
Prime Medicine announced yesterday a new preclinical program for treating alpha-1 antitrypsin deficiency (AATD), a genetic disorder affecting lung and liver function. The announcement included ...
Prime Medicine announced yesterday a new preclinical ... On rare occasions, our expert team of analysts issues a “Double Down” stock recommendation for companies that they think are about ...